Quinagolide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 87056-78-8 |
| ATC code | G02CB04 |
| PubChem | CID 55645 |
| ChemSpider | 2343034 |
| UNII | 80Q9QWN15M |
| KEGG | D07217 |
| ChEMBL | CHEMBL290962 |
| Chemical data | |
| Formula | C20H33N3O3S |
| Mol. mass | 395.56 g/mol |
|
|
| |
Quinagolide (Norprolac) is a selective, D2 receptor agonist that is used for the treatment of elevated levels of prolactin.[1]
[edit] See also
[edit] References
- ^ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x.
|
|

